In essence, the dysregulation of gut microbiota triggers a complex cascade of adverse effects, including compromised intestinal epithelial barrier integrity, increased inflammation, oxidative stress, reduced insulin sensitivity, renal fibrosis, and the progressive development of DN. The gene discussed is INS; the disease is liver dysplastic nodule.